The assessment of the effect of plasmapheresis treatment for the management of sever COVID-19 patients

Not Applicable

Recruiting

• Conditions: Covid-19,Plasmapheresis.; Coronavirus infection, unspecified; B34.2

• Registration Number: IRCT20200414047076N2
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 November 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Age over 18 years
No pregnancy
Do not get diseases that require a special treatment protocol
Patient with cytokine storm
Life-threatening illnesses such as respiratory failure, septic shock, dysfunction or multiple organ failure
early ARDS

Exclusion Criteria

Age under 18 years
pregnancy

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The prevalence of mortality/morbidity. Timepoint: Three plasmapheres with one or two days apart, examinations and tests in both groups every other day for two weeks and then every week for two weeks. Method of measurement: Patients' lab and file records.